Philips Scoops Up Clearance for Expression MR400

The FDA has given Royal Philips 510(k) clearance for its Expression MR400, a new technology that monitors patients undergoing magnetic resonance imaging.

The product warns clinicians of severe medical changes and provides a comprehensive approach in monitoring the patients, the company said.

The MR400 provides ICU-comparable, bedside quality monitoring in the MR suite for all patients, including those with serious medical conditions or who require anesthesia. — Jonathon Shacat